Parents of 51.7 million children now qualify for the new Education Freedom Tax Credit for scholarships, according to a new estimate released by its proponents.
Pitching an institutional investor on a single private equity deal rather than a diversified fund was long deemed the sign of a buyout newcomer or a struggling rainmaker.
As GSK records $2.4 billion in impairment charges for the second quarter, the U.K. pharma has announced a sweeping restructure designed to save about the same amount of money over the next few years.
When signing a biotech licensing deal in China, experts say that pharma’s patent attorneys need to understand the geopolitical risk of the BIOSECURE Act.
There’s little consistency in how businesses across different countries can deduct their capital investments as depreciation, according to a new study.